Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Liquid Biopsy in Thyroid Cancer: New Insight



Khatami F1 ; Tavangar SM1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: International Journal of Hematology-Oncology and Stem Cell Research Published:2018

Abstract

Thyroid cancer, one of the most widespread malignancies of the endocrine-related system that over the past three decades, has a vivid increasing rate. The diagnosis and management of it is dependent on the tumor type and stage. Thyroid cancer is divided into four main types, including PTC (papillary thyroid carcinoma), FTC (follicular thyroid carcinoma), MTC (medullarly thyroid carcinoma), and ATC (anaplastic thyroid carcinoma). The development of the noninvasive diagnostic tool for plasma genotyping, also known as “liquid biopsy”, brings a new insight for cancer diagnosis and prognosis. It is mainly containing circulating tumor DNA (ctDNA), circulating tumor cell (CTC), exosomes and extrachromosomal circular DNA (ecDNA). Liquid biopsy as a new plasma genotyping source brings a new prospective of tumor monitoring and therapy. It beneficially reduces the need of tissue biopsy and made early recognition of relapse as well. This article summarizes its components characteristics and their benefit in diagnosis and treatment of thyroid cancer. © 2018, Tehran University of Medical Sciences (TUMS). All rights reserved.
Other Related Docs
10. Genetic and Epigenetic of Medullary Thyroid Cancer, Iranian Biomedical Journal (2018)
11. Personalized Treatment Options for Thyroid Cancer: Current Perspectives, Pharmacogenomics and Personalized Medicine (2019)
12. A Review of Driver Genetic Alterations in Thyroid Cancers, Iranian Journal of Pathology (2018)
18. Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report, International Journal of Hematology-Oncology and Stem Cell Research (2018)
21. Liquid Biopsy in Kidney Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
23. Circulating Tumor Braf Mutation and Personalized Thyroid Cancer Treatment, Asian Pacific Journal of Cancer Prevention (2017)
25. The Emerging Role of Succinate Dehyrogenase Genes (Sdhx) in Tumorigenesis, International Journal of Hematology-Oncology and Stem Cell Research (2019)
26. Overview of Liquid Biopsy, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
27. Tumor-Educated Platelets, Clinica Chimica Acta (2024)
28. Oncometabolites: A New Insight for Oncology, Molecular Genetics and Genomic Medicine (2019)
35. Clear Cell Sarcoma: A Case Report and Review of Literature, International Journal of Hematology-Oncology and Stem Cell Research (2018)
38. Virus, Exosome, and Microrna: New Insights Into Autophagy, Advances in Experimental Medicine and Biology (2022)
44. Role of Gata3 in Tumor Diagnosis: A Review, Pathology Research and Practice (2021)
45. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
50. Liquid Biopsy in Male Genital Tract: Testis Tumor, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)